Taking Ozempic triggers a cascade of changes in your body, from how quickly your stomach empties to how your brain registers hunger. Most people notice reduced appetite within the first few weeks, followed by gradual weight loss and, for those with type 2 diabetes, meaningful drops in blood sugar. But the drug also comes with common side effects, some rare but serious risks, and a significant rebound effect if you stop taking it.
How Ozempic Works in Your Body
Ozempic (semaglutide) mimics a hormone your gut naturally releases after eating. This hormone tells your pancreas to produce more insulin when blood sugar rises, slows the rate at which food leaves your stomach, and sends signals to your brain that reduce appetite. Because the drug is a longer-lasting version of this natural hormone, a single weekly injection keeps these effects going around the clock.
The slowed stomach emptying is responsible for both the appetite suppression and many of the digestive side effects people experience early on. Food sits in your stomach longer, so you feel full faster and stay full longer. For many people, the mental “noise” around food, constant cravings and food-focused thoughts, quiets down noticeably.
The Dose Ramp-Up Schedule
You don’t start at a full dose. The first four weeks are spent on a very low 0.25 mg weekly injection, which is designed to let your body adjust rather than to produce major results. At week five, your dose increases to 0.5 mg. From there, your doctor may raise it to 1 mg after at least another four weeks, with a maximum dose of 2 mg once a week. This gradual escalation matters because jumping to a higher dose too quickly tends to make side effects, especially nausea, significantly worse.
What Happens to Your Blood Sugar
For people with type 2 diabetes, Ozempic produces a clinically significant improvement in blood sugar control. In real-world data from over 1,200 patients who stayed on the medication, average HbA1c (a measure of blood sugar over the previous two to three months) dropped by 1.4 percentage points. Even across all users, including those who didn’t stick with treatment, the average reduction was 1.2 points. To put that in perspective, most diabetes medications aim for a reduction of 0.5 to 1.0 points, so this is a substantial shift.
The blood sugar effects begin within the first few weeks but take two to three months to fully show up on lab work, since HbA1c reflects a rolling average.
Weight Loss: How Much and How Fast
Weight loss is gradual, not dramatic overnight. In clinical trials, participants using semaglutide alongside a reduced-calorie diet and exercise lost an average of 14.9% of their body weight over 68 weeks, roughly 16 months. For someone weighing 220 pounds, that translates to about 33 pounds.
Most people see minimal weight change during the first month on the starter dose. Noticeable loss typically begins around months two and three as the dose increases, with the most significant changes happening between months three and twelve. Weight loss tends to plateau somewhere between months 12 and 16.
One important caveat: not all of that lost weight is fat. Research published in Circulation found that up to 40 to 45% of total weight lost on semaglutide can come from lean mass, which includes muscle. In one major trial, participants lost about 15 kg total, and roughly 7 kg of that was lean mass. This is a higher lean-mass-to-fat ratio than most people expect from a weight loss drug, and it’s why many doctors now recommend resistance training alongside Ozempic to help preserve muscle.
Common Side Effects
The most frequently reported side effects are gastrointestinal, and they tend to cluster in the early weeks or after each dose increase. Nausea is the most common, affecting a large percentage of users. Vomiting, diarrhea, constipation, and stomach pain are also typical. For most people, these symptoms are mild to moderate and fade as the body adjusts over a few weeks.
Some people experience what’s sometimes called “sulfur burps,” a distinctive rotten-egg belching that comes from the slowed digestion. Fatigue and headaches also show up, particularly in the first month. Eating smaller meals, avoiding fatty or greasy foods, and eating slowly can help manage the digestive symptoms during the adjustment period.
Rare but Serious Risks
Ozempic carries an FDA boxed warning, the most serious type of safety alert, related to thyroid tumors. In animal studies, semaglutide caused thyroid C-cell tumors in rodents. Whether this translates to humans is still unknown, but the drug is contraindicated for anyone with a personal or family history of medullary thyroid carcinoma or a condition called Multiple Endocrine Neoplasia syndrome type 2. Signs to watch for include a lump in the neck, difficulty swallowing, shortness of breath, or persistent hoarseness.
Pancreatitis is another concern. Semaglutide users develop pancreas inflammation at a rate of about 5 cases per 1,000 users per year. Compared to people taking a different weight loss medication (bupropion-naltrexone), those on GLP-1 drugs like Ozempic had roughly nine times the risk of pancreatitis. The absolute risk is still low, but severe, persistent abdominal pain radiating to the back warrants immediate medical attention.
Gastroparesis, a condition where the stomach loses its ability to empty normally, occurred at a rate of about 10 cases per 1,000 semaglutide users per year, nearly four times the rate seen with other weight loss medications. Bowel obstruction risk was also elevated, at about four times the comparison rate. These complications are uncommon but worth knowing about, particularly if you have pre-existing digestive conditions.
What Happens When You Stop
This is where many people are caught off guard. Stopping Ozempic leads to rapid weight regain. A 2025 systematic review in The BMJ found that people regain weight at an average rate of 0.8 kg (about 1.75 pounds) per month after stopping newer drugs like semaglutide. At that pace, the estimated regain was 9.9 kg (roughly 22 pounds) within the first year, with a projected return to baseline weight by about 1.5 years after stopping.
It’s not just the weight. Blood sugar, blood pressure, cholesterol, and triglycerides all trend back toward their pre-treatment levels. Fasting glucose, systolic blood pressure, and cholesterol are projected to return to baseline within a year of stopping, with HbA1c following by about 1.4 years. This pattern is why many doctors frame Ozempic as a long-term or indefinite medication rather than a short course of treatment.
The appetite suppression fades as the drug clears your system, which takes a few weeks given its long half-life. Many people report that the cravings and food-focused thinking return, sometimes intensely, as semaglutide levels drop. This rebound in hunger, combined with a metabolism that has adjusted to a lower body weight, drives the regain.
Effects on Heart Health
Beyond blood sugar and weight, semaglutide appears to reduce cardiovascular risk. The SELECT trial demonstrated a reduction in major adverse cardiovascular events (heart attack, stroke, and cardiovascular death) in people with obesity and established heart disease. This is one of the reasons the drug has gained attention beyond its original diabetes indication. The cardiovascular benefits, like the metabolic improvements, appear to depend on continued use of the medication.